Home
News
Create
Screeners
Insights
Alpa Laboratories
61.
49
-0.21
(-0.34%)
Market Cap
₹129.38 Cr
PE Ratio
11.67
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-0.34%
1M
-14.66%
6M
-35.57%
1Y
-41.55%
5Y
+56.86%
View Company Insights
Latest news about Alpa Laboratories
Alpa Laboratories Reports Promoter Share Transfer Under SEBI SAST Regulations
3 days ago
Alpa Laboratories Limited has completed a promoter group share transfer involving 21,940 equity shares (0.10% of share capital) transferred as a gift from Bakulesh Chandulal Shah HUF to Mr. Vinit Shah on March 7, 2026. The transaction was conducted as an off-market inter se transfer between immediate relatives under SEBI SAST Regulations, with comprehensive disclosures filed under Regulations 10(6), 29(1), and 29(2). The company confirmed no net change in total promoter group shareholding, maintaining compliance with regulatory requirements.
Alpa Laboratories Company Secretary Ms. Srashiti Chopra Resigns Due to Personal Reasons
Feb 25, 2026
Alpa Laboratories Reports Q3FY26 Results with Revenue Growth of 13.5% YoY
Feb 11, 2026
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO